Tag: Retinopathy of prematurity

Research status of different doses of anti-vascular endothelial growth factor drugs in retinopathy of prematurity

Authors: Jiang Keke,  Zhang Jie DOI: 10.3760/cma.j.cn115989-20200809-00573 Published 2024-07-10 Cite as Chin J Exp Ophthalmol, 2024, 42(7): 669-674. Abstract                            【Download PDF】【Read Full Text】 With the further study of vascular endothelial growth factor (VEGF) in the pathogenesis of retinopathy of prematurity (ROP), a variety […]

Metabolomics study of kidney tissue in a mouse model of oxygen-induced retinopathy

Authors: Dong Lijun,  Qi Hui,  Yang Yuhang,  Mao Xingxing,  Zhang Guoming,  Zhang Shaochong,  Lei Hetian DOI: 10.3760/cma.j.cn115989-20220526-00248 Published 2024-01-10 Cite as Chin J Exp Ophthalmol, 2024, 42(1): 19-28. Abstract                              [Download PDF] [Read Full Text] Objective To explore the effects of hyperoxic environments […]

Effect of anti-VEGF intravitreal injections on the development of nervous system in retinopathy of prematurity

Authors: Tian Ya,  Zhang Fuyan,  Zhang Guoming DOI: 10.3760/cma.j.cn115989-20200731-00548 Published 2022-03-10 Cite asChin J Exp Ophthalmol, 2022, 40(3): 271-275. Abstract                              [View PDF] [Read Full Text] Retinopathy of prematurity (ROP) is a blinding eye disease characterized by abnormal proliferation of retinal blood vessels in children.Vascular endothelial […]

Comparison of long-term macular morphology after laser retinal photocoagulation and anti-VEGF therapy and their effects on vision prognosis for type 1 ROP

Authors: Guo Lili,  Cheng Yong,  Deng Xun,  Linghu Dandan,  Zhu Xuemei,  Shi Xuan,  Li Xiaoxin,  Liang Jianhong DOI: 10.3760/cma.j.cn115989-20210913-00508 Published 2022-01-10 Cite asChin J Exp Ophthalmol, 2022, 40(1): 47-53. Abstract                              [View PDF] [Read Full Text]  Objective To evaluate and compare the foveal […]